Sustainability innovation
or primary care. The laboratory may currently provide MSU collection kits to clinical settings. Also, they may need to consider the collection tube, whether to retain the urinalysis tube or change. There should be early discussion held with your Microbiology Laboratory so that the urinalysis step can be reviewed and the implications for changing the pre-analytic step. A sustainability review can address
potential life cycle carbon analysis of current pathways for MSU collection and analysis and a comparison. Infection and Prevention team oversight is important of any clinical evaluation within key care settings to help generate patient feedback and staff feedback; that in turn can be used as part of a clinical product review. Your IPC Doctor (Microbiologist) should also be consulted to ensure they are comfortable with the microbiological safety of the PiP. Also, there is additional data to show that there is no fibre shedding and hence potential interference with microscopy, which is a different finding to other types of pulp products designed with different uses in mind. Your clinical procurement lead may be
able to use the product codes of consumable items commonly used in the MSU collection process to determine the health economic implications of changing practice. There may be a cost-saving to be made overall and in specific clinical pathways. This can be informed by a visual process
map of what consumable items are being used for the initial MSU specimen collection and supply in a container to your pathology lab both in a secondary care, community, and primary care setting.
Conclusion The PiP represents a disruptive home-grown innovation with sustainability credentials that offers a cost-effective means of standardising the collection of a midstream urine specimen in the case of a suspected UTI, and an opportunity to reduce the carbon footprint of the MSU collection and processing pathway. The PiP is the first white pulp product
registered for urine collection, listed within the medical pulp category of NHS Supply Chain (product code: FBF85178) Samples for evaluation can be requested from our manufacturing partner via our website. Somerset NHS FT welcomes enquiries and is willing to share insights and lessons learned regarding engagement strategies for stakeholders in MSU collection and processing pathway transformation.
CSJ
Please contact
peeinpot@somersetft.nhs.uk or visit:
https://peeinpot.com/
February 2026 I
www.clinicalservicesjournal.com 53 About the authors
Nick Burns-Cox, Consultant Urological Surgeon MD FRCS (Urol), was appointed as a consultant urological surgeon to Somerset in 2005. He has a special interest in robotic/
minimally invasive surgery of the kidneys and the diagnostic pathway for suspected prostate cancer. He also has a special interest in innovation and in trying to improve quality and patient experience.
Other contributors include: Tracey Doolan-RGN, Infection Control Nurse & PiP IPC Project Lead, Somerset;
Nael Clarke-BSc MPhil (Oncology) MBA, Director of Commercial Development , Chair of the Somerset NHS FT Innovation Forum and Member of the Strategic Sustainability Group for the Trust- an advocate for support of NHS-derived innovations.
Victoria Welsh, Bid Lead and Innovation Discovery Manager, Clinical Entrepreneur Programme (Cohort 7), Registered Physiotherapist, Somerset
Somerset NHS Foundation Trust is an integrated care provider of Secondary Care, Mental Health and Learning Disability Services, Community Services and Primary Care Services spanning the County of Somerset.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
